Related Experiment Videos
Left ventricular wall motion improvement after phentolamine: a case report
Angiology
|January 1, 1982
Summary
Phentolamine can identify reversible left ventricular wall motion abnormalities in coronary artery disease patients. This agent helps predict which patients may benefit from surgical correction by detecting areas of potential recovery.
Area of Science:
- Cardiology
- Medical Imaging
- Pharmacology
Background:
- Left ventricular wall motion abnormalities are common in patients with coronary artery disease (CAD).
- Distinguishing between reversible ischemia and irreversible damage is crucial for surgical planning.
- Predicting improved ventricular function post-surgery relies on identifying viable myocardial tissue.
Observation:
- A single patient with CAD presented with impaired septal movement on echocardiography.
- Intravenous administration of phentolamine was performed.
- Post-administration, the septal movement normalized.
Findings:
- Phentolamine effectively improved the observed septal wall motion abnormality.
- The drug demonstrated a capacity to differentiate between potentially viable and non-viable myocardial segments.
- This suggests phentolamine can unmask reversible dysfunction.
Implications:
- Phentolamine may serve as a valuable diagnostic tool for assessing myocardial viability in CAD.
- It could aid in selecting patients who are most likely to benefit from revascularization procedures.
- Further research into phentolamine's role in evaluating wall motion abnormalities is warranted.